Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Department of Angiology and Vascular Surgery, Centro Hospitalar São João, Porto, Portugal; Department of Surgery and Physiology, Faculty of Medicine of Oporto, Porto, Portugal.
J Endovasc Ther. 2021 Feb;28(1):146-156. doi: 10.1177/1526602820962484. Epub 2020 Oct 7.
To compare changes in abdominal aortic aneurysm (AAA) sac volume between endovascular aneurysm repairs (EVAR) performed for ruptured (rEVAR) vs intact (iEVAR) AAAs and to determine the impact of early volume shrinkage on future complications.
A retrospective analysis was performed of all patients undergoing standard infrarenal EVAR from 2002 to 2016 at a tertiary referral institution. Only patients with degenerative AAAs and with 30-day and 1-year computed tomography angiography (CTA) imaging were included. Early sac shrinkage was defined as a volume sac reduction >10% between the first (<30-day) and the 1-year CTA. The primary endpoint was to compare AAA sac volume changes between patients undergoing rEVAR (n=51; mean age 71.0±8.5 years; 46 men) vs iEVAR (n=393; mean age 72.3±7.5 years; 350 men). Results are reported as the mean difference with the interquartile range (IQR Q1, Q3). The secondary endpoint was freedom from aneurysm-related complications after 1 year as determined by regression analysis; the results are presented as the hazard ratio (HR) and 95% confidence interval (CI).
At baseline, the rEVAR group had larger aneurysms (p<0.001) and shorter (p<0.001) and more angulated (p=0.028) necks. Aneurysm sac volume decreased more in the rEVAR group during the first year [-26.3% (IQR -38.8%, -12.5%)] vs the iEVAR group [-11.9% (IQR -27.5%, 0); p<0.001]. However, after the first year, the change in sac volume was similar between the groups [-3.8% (IQR -32.9%, 31.9%) for rEVAR and -1.5% (IQR -20.9%, 13.6%) for iEVAR, p=0.74]. Endoleak occurrence during follow-up was similar between the groups. In the overall population, patients with early sac shrinkage had a lower incidence of complications after the 1-year examination (adjusted HR 0.59, 95% CI 0.39 to 0.89, p=0.01).
EVAR patients treated for rupture have more pronounced aneurysm sac shrinkage compared with iEVAR patients during the first year after EVAR. Patients presenting with early shrinkage are less likely to encounter late complications. These parameters may be considered when tailoring surveillance protocols.
比较破裂性腹主动脉瘤(rEVAR)与非破裂性腹主动脉瘤(iEVAR)行血管内修复术(EVAR)后腹主动脉瘤瘤腔体积的变化,并确定早期体积收缩对未来并发症的影响。
对 2002 年至 2016 年在一家三级转诊机构行标准肾下 EVAR 的所有患者进行回顾性分析。仅纳入退行性腹主动脉瘤患者,且均行 30 天和 1 年 CT 血管造影(CTA)检查。早期瘤腔缩小定义为第 1 次(<30 天)和 1 年 CTA 之间的瘤腔体积缩小>10%。主要终点是比较破裂性 EVAR 治疗组(n=51;平均年龄 71.0±8.5 岁;46 例男性)和非破裂性 EVAR 治疗组(n=393;平均年龄 72.3±7.5 岁;350 例男性)患者的腹主动脉瘤瘤腔体积变化。结果以平均值和四分位距(IQR Q1,Q3)表示。次要终点是通过回归分析确定 1 年后无动脉瘤相关并发症的患者比例;结果以风险比(HR)和 95%置信区间(CI)表示。
基线时,rEVAR 组的瘤体更大(p<0.001),瘤颈更短(p<0.001)且更扭曲(p=0.028)。rEVAR 组患者在第 1 年的瘤腔体积缩小更明显[-26.3%(IQR -38.8%,-12.5%)],而 iEVAR 组患者的瘤腔体积缩小相对较少[-11.9%(IQR -27.5%,0);p<0.001]。然而,第 1 年之后,两组患者的瘤腔体积变化相似[-3.8%(IQR -32.9%,31.9%),rEVAR 组;-1.5%(IQR -20.9%,13.6%),iEVAR 组,p=0.74]。两组患者在随访期间的内漏发生率相似。在总体人群中,与第 1 年检查时相比,早期瘤腔缩小的患者发生并发症的几率较低(校正 HR 0.59,95%CI 0.39 至 0.89,p=0.01)。
与 iEVAR 患者相比,破裂性 EVAR 治疗的患者在 EVAR 后第 1 年的瘤腔体积缩小更为明显。出现早期缩小的患者发生晚期并发症的可能性较低。在制定监测方案时可以考虑这些参数。